Wan Yee Lau
机构：Army Medical University, Sun Yat-sen University, Ratio, Chinese University of Hong Kong, Second Military Medical University, Predict (France), Prince of Wales Hospital, Southwest Hospital, Eastern Hepatobiliary Surgery Hospital, Beijing Drainage Group (China), Sun Yat-sen University Cancer Center, Institut für Bauwerkserhaltung und Sanierung (Germany), National Comprehensive Cancer Network · ORCID：0000-0002-6686-5440
发表论文 618 篇 · 总被引 34456 次 · h-index 86
代表论文
- Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial (2024 · Nature Medicine · 被引 130)
- Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial (2024 · The Lancet. Gastroenterology & hepatology · 被引 115)
- Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma (2024 · JAMA Oncology · 被引 56)
- Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study (2024 · International Journal of Surgery · 被引 38)
- Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort study (2024 · International Journal of Surgery · 被引 24)
- Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis (2024 · Frontiers in Immunology · 被引 21)